Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer

Purpose: To investigate the clinical value of Clinical Treatment Score Post-5 Years (CTS5) to predict the survival benefits of postmastectomy radiotherapy (PMRT) of patients with T1-2N1 luminal breast cancer (BC). Methods: Patients who were diagnosed with T1-2N1 luminal BC between 2010 and 2015 were...

Full description

Saved in:
Bibliographic Details
Main Authors: Ke Liu, Guan-Qiao Li, Si-Qi Li, Xue-Qin Chen, San-Gang Wu
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625000025
Tags: Add Tag
No Tags, Be the first to tag this record!